-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse Börse MünchenEURSymbol 44O
Symbol 44O
Währung
EUR
Börse
Börse München Zeitzone: America/New_York
Marktkapitalisierung
4.261.000.000
Mitarbeiter
523
Entdecke die 6 ETFs in denen Beam Therapeutics am höchsten gewichtet ist Insgesamt in 9 ETFs enthalten
Dir gefallen die Informationen zu Beam Therapeutics?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Beam Therapeutics?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Beam Therapeutics?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Beam Therapeutics?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
32 News & Informationen zur Beam Therapeutics Aktie
S&P, NASDAQ Set New Highs While Waiting for Jobs Report
Stocks Analysis by Zacks Investment Research covering: Cross Country Healthcare Inc, Pacific Biosciences of California, Materion Corporation, Editas Medicine Inc. Read Zacks Investment Research's latest article on Investing.com
Cathie Wood’s ARK Invest Buys for 8
Here's a look at the ARK Invest buys for August 4, 2021.
Beam Therapeutics To Participate In The 2021 Wedbush PacGrow Healthcare Conference
CAMBRIDGE, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines
3 Healthcare Stocks That Could Make You Rich
They're disruptors that could change healthcare.
Cathie Wood’s ARK Invest Buys for 7
Here's a look at the ARK Invest buys for July 19, 2021.
Cathie Wood’s ARK Invest Buys for 7
Here's a look at the ARK Invest buys for July 16, 2021.
Why CRISPR Therapeutics, Editas Medicine, and Beam Therapeutics Dropped This Week
After rallying on the coattails of Intelllia's breakthrough, these companies have given back their June gains.
Verve Therapeutics Gets Off to a Fast Start
GuruFocus Article or News written by Barry Cohen and the topic is about: Shares of gene editing biotech up nearly 170% since mid-June IPO
Hedge Funds Are Selling Flowers Foods, Inc. (FLO)
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession…
Should I Buy Petco Health and Wellness Company, Inc. (WOOF)?
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the first quarter,…
Is It Too Late to Buy Intellia Therapeutics?
After skyrocketing 68% last week, will this stock keep running higher?
Beam Therapeutics Inc (BEAM) CEO John M. Evans Sold $2.7 million of Shares
GuruFocus Article or News written by insider and the topic is about:
Why Beam Therapeutics Climbed 64.5% in June
A gene editing milestone sent the entire sector higher last month.
Hot Small-Cap Stocks To Watch With Potential Cancer Breakthroughs
Here's What Drove Gene Editing Stocks Higher This Week
The most exciting clinical trial data in the medical community has huge implications for Intellia, and its peers.
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET Friday, 146 stocks hit new 52-week highs.
Interesting Facts: The largest company by market cap to set a new 52-week high was …
Caribou Biosciences is going public. Here’s an intro to the company and their revolutionary gene-editing technology. : investing
Disclaimer and disclosure: I am not a financial advisor and none of the below research constitutes investment advice or a recommendation to buy or …
Stocks That Hit 52-Week Highs On Thursday
This morning 158 companies set new 52-week highs.
Intriguing Points: NVIDIA (NASDAQ:NVDA) was the largest firm on a market cap basis to set a …
New Gene Editing Trial Results Bump the ARKG ETF
Shares of Intellia Therapeutics surged Monday after the firm announced positive results for an in vivo genome editing therapy known as NTLA-2001.
Why Beam Therapeutics Jumped Today
A first for CRISPR-Cas9 might signal a new phase in the gene-editing revolution.
Beam Therapeutics Gains 16%
Shares of Beam Therapeutics Inc. (BEAM) are up more than 16% Monday morning at $109.85..
24 Stocks Moving in Monday's Pre-Market Session
Gainers Intellia Therapeutics, Inc. (NASDAQ:NTLA) rose 28.9% to $114.49 in pre-market trading. Intellia Therapeutics and Regeneron Pharmaceutica…
Cormorant Asset Management, LLC Buys Design Therapeutics Inc, Edgewise Therapeutics Inc, Tarsus Pharmaceuticals Inc, Sells Beam Therapeutics Inc, Immunovant Inc,
GuruFocus Article or News written by insider and the topic is about:
Redmile Group, LLC Buys Jazz Pharmaceuticals PLC, Seagen Inc, Medtronic PLC, Sells AbbVie Inc, Gilead Sciences Inc, 1Life Healthcare Inc
GuruFocus Article or News written by insider and the topic is about:
Cathie Wood Trims Tesla Stake And Loads Up Heavily On Coinbase
Cathie Wood-led Ark Investment Management on Wednesday bought nearly 750,000 shares of Coinbase Global Inc (NASDAQ:COIN), on the day the cryp…
Opinion: Biotech stocks are a buy — especially these 18 picks
The sector's recent pullback offers an chance to get into exciting areas of biotech research like gene editing and oncology at better prices.
Stocks That Hit 52-Week Highs On Friday
This morning 150 companies reached new 52-week highs.
Interesting Points: Eli Lilly (NYSE:LLY) was the largest firm by market cap to set a new …
The buzzy biotech Verve is gearing up to test a gene-editing treatment that could cure heart disease. The CEO shares his 3-step vision for the one-and-done heart treatment.
“Ultimately, this medicine, if effective and safe, will be a one-and-done for heart attack,” Verve CEO Sekar Kathiresan told Insider.
Beam Therapeutics: A Gene Editing Stock
Beam Therapeutics Inc. (NASDAQ:BEAM), founded in 2017, is a biotech firm working on CRISPR 2.0, which is an advanced base editing technology that targets…
Stocks That Hit 52-Week Highs On Friday
This morning 470 companies set new 52-week highs.
Facts of Interest: Tesla (NASDAQ:TSLA) was the largest firm on a market cap basis to set a …
Crispr Gene-Editing Treatment Could Point Way to Fix for Deadly Aging Disease
Scientists used a version of Crispr gene editing to significantly extend the lifespan of mice with progeria, a rare disease that causes rapid aging and early death in children.
Implied Volatility Surging for Beam Therapeutics (BEAM) Stock Options
Investors need to pay close attention to Beam Therapeutics (BEAM) stock based on the movements in the options market lately.